[1] 赵辨. 临床皮肤病学[M]. 3. 南京:江苏科技出版社,2001.1363. [2] Stierman S C, Tierney E P, Shwayder T A. Halo congenital nevocellular nevi associated with extralesional vitiligo: a case series with review of the literature.[J]. Pediatr Dermatol,2009,26(4):414-424. [3] Leow L J, Goh B K. Halo congenital naevus in a middle-aged patient with vitiligo.[J]. Australas J Dermatol,2008,49(4):229-232. [4] Ohtsuka T. Multiple Sutton nevi: Hypomelanocytic halo development around 28 melanocytic nevi[J]. J Dermatol,2009,36(6):355-357. [5] 邢传平，曹晓哲，李宁，等. 先天性巨形色素痣伴发平滑肌瘤1例[J]. 临床皮肤科杂志,1998(02):118-119. [6] Mishra D, Sardana K. Giant congenital pigmented nevus of scalp.[J]. Indian Pediatr,2010,47(6):521. [7] Yu H S, Kao C H, Yu C L. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo.[J]. J Invest Dermatol,1993,100(6):823-828. [8] Baharav E, Merimski O, Shoenfeld Y, et al. Tyrosinase as an autoantigen in patients with vitiligo.[J]. Clin Exp Immunol,1996,105(1):84-88. [9] Harning R, Cui J, Bystryn J C. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo.[J]. J Invest Dermatol,1991,97(6):1078-1080. [10] 崔建，沈丽玉. 450例白癜风临床分析[J]. 临床皮肤科杂志,1989,18(3):123-125. [11] 金城，陆洪光，赵志国，等. 晕痣的免疫组化特点与自发性消退机制的研究[J]. 中华皮肤科杂志,2008,41(4).